Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
69.54
-0.66 (-0.94%)
At close: Nov 20, 2024, 4:00 PM
69.46
-0.08 (-0.12%)
Pre-market: Nov 21, 2024, 7:13 AM EST
Edwards Lifesciences Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for EW stock have an average target of 76.6, with a low estimate of 63 and a high estimate of 105. The average target predicts an increase of 10.15% from the current stock price of 69.54.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for EW stock from 21 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 7 | 4 | 4 | 4 | 4 | 4 |
Buy | 7 | 5 | 5 | 5 | 4 | 4 |
Hold | 5 | 11 | 11 | 13 | 13 | 13 |
Sell | 1 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 20 | 20 | 22 | 21 | 21 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Hold Maintains $66 → $63 | Hold | Maintains | $66 → $63 | -9.40% | Oct 25, 2024 |
JP Morgan | JP Morgan | Hold Maintains $72 → $78 | Hold | Maintains | $72 → $78 | +12.17% | Oct 25, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $73 → $70 | Hold | Maintains | $73 → $70 | +0.66% | Oct 25, 2024 |
Truist Securities | Truist Securities | Hold Maintains $71 → $70 | Hold | Maintains | $71 → $70 | +0.66% | Oct 25, 2024 |
Baird | Baird | Hold Maintains $73 → $68 | Hold | Maintains | $73 → $68 | -2.21% | Oct 25, 2024 |
Financial Forecast
Revenue This Year
6.03B
from 6.00B
Increased by 0.34%
Revenue Next Year
6.12B
from 6.03B
Increased by 1.64%
EPS This Year
2.61
from 2.30
Increased by 13.33%
EPS Next Year
2.52
from 2.61
Decreased by -3.20%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 6.8B | 7.3B | 8.2B | ||
Avg | 6.0B | 6.1B | 6.7B | ||
Low | 5.3B | 5.7B | 6.1B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 12.8% | 21.2% | 33.7% | ||
Avg | 0.3% | 1.6% | 9.7% | ||
Low | -11.6% | -5.5% | -0.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.86 | 3.02 | 3.74 | ||
Avg | 2.61 | 2.52 | 2.87 | ||
Low | 2.09 | 2.28 | 2.55 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 24.2% | 16.0% | 48.1% | ||
Avg | 13.3% | -3.2% | 13.9% | ||
Low | -9.2% | -12.4% | 1.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.